ALNY
$ALNY
Alnylam Pharmaceuticals, Inc.
Pioneer in RNA interference therapeutics treating rare genetic diseases.
Healthcare$311.10
-3.70 (-1.18%)
Day Range$309.73 - $317.61
Prev Close$314.80
Analyst Rating
Strong Buy
28 Buy / 8 Hold / 0 Sell
Subscribers
0
Tracking this ticker
Next Report
Sun, Mar 22
Weekly updates
Latest Report
ALNY: RNAi Leader, Growth vs Valuation
Alnylam (ALNY) remains a leader in RNAi therapeutics with expanding commercial revenue, a profitable track record and analyst upside near 46%. High multiples and pipeline execution risk create the main counterpoints.
Mar 16, 2026